MENU
+Compare
PCVX
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$45.56
Change
-$0.54 (-1.17%)
Capitalization
5.96B

PCVX Vaxcyte Forecast, Technical & Fundamental Analysis

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases... Show more

PCVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PCVX with price predictions
Nov 12, 2025

Aroon Indicator for PCVX shows an upward move is likely

PCVX's Aroon Indicator triggered a bullish signal on November 06, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 232 similar instances where the Aroon Indicator showed a similar pattern. In of the 232 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on PCVX as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PCVX advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PCVX moved out of overbought territory on October 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for PCVX turned negative on October 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PCVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.061) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.723).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PCVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PCVX is expected to report earnings to fall 16.67% to -129 cents per share on March 02

Vaxcyte PCVX Stock Earnings Reports
Q4'25
Est.
$-1.30
Q3'25
Missed
by $0.32
Q2'25
Missed
by $0.05
Q1'25
Est.
$-1.04
Q4'24
Beat
by $0.10
The last earnings report on November 04 showed earnings per share of -155 cents, missing the estimate of -124 cents. With 1.44M shares outstanding, the current market capitalization sits at 5.96B.
A.I. Advisor
published General Information

General Information

a company which engages in development of vaccines for infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
825 Industrial Road
Phone
+1 650 837-0111
Employees
254
Web
https://www.vaxcyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEUCX63.140.47
+0.75%
American Funds EUPAC 529-C
IHOIX23.180.12
+0.52%
Hartford International Opportunities I
JHJCX23.920.06
+0.25%
JHancock ESG Large Cap Core C
CMCRX45.150.10
+0.22%
Calvert US Mid Cap Core Rspnb Idx R6
AVUVX17.940.03
+0.17%
Avantis® U.S. Small Cap Value Instl

PCVX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with NUVL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+0.96%
NUVL - PCVX
47%
Loosely correlated
+0.91%
IDYA - PCVX
47%
Loosely correlated
-0.19%
KYMR - PCVX
47%
Loosely correlated
+0.25%
TSHA - PCVX
45%
Loosely correlated
+1.87%
BEAM - PCVX
45%
Loosely correlated
-2.71%
More